Bromfenac Solution/ Drops
Product Images NDC 68083-313

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bromfenac (NDC 68083-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bromfenac-spl-carton.jpg (Bromfenac Spl Carton)

Bromfenac-spl-carton.jpg (Bromfenac Spl Carton)
This text appears to be a mix of misspelled words and fragmented sentences with incomplete words. Therefore, it is not possible to generate a useful description of its content.*
FDA Label Image

Bromfenac-spl-container.jpg (Bromfenac Spl Container)

Bromfenac-spl-container.jpg (Bromfenac Spl Container)
NDC 68083-313-01 is an ophthalmic solution containing 1.7 mL of Bromfenac for topical application in the eye. It is intended for once-daily use and is available only by prescription. The solution should be stored at 15° to 25°C (59° to 77°F). It is manufactured by Gland Pharma Limited in SA80 Hyderabad, India and is labeled with M.L. No.: 103/AP/RR/97/FIR. Additional text is not available.*
FDA Label Image

Bromfenac-spl-structure (Bromfenac Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.